Due to COVID-19 Vaccine Hopes, Intraday Surge to 2220 Level... KOSDAQ Up 0.6%

Rising Expectations for Earnings Improvement Boost Non-Face-to-Face Stocks
Pharmaceutical and Bio Stocks Surge Amid Interest in COVID-19 Treatments and Vaccine Development

[Asia Economy Reporter Oh Ju-yeon] On the 20th (local time), fueled by the rise in the New York stock market following expectations for the development of a novel coronavirus (COVID-19) vaccine, the domestic stock market surpassed the resistance level of KOSPI 2200 and climbed to 2220 during the session. In particular, the strength of non-face-to-face (untact) related stocks with high expectations for earnings improvement stood out.

According to the Korea Exchange on the 21st, the KOSPI opened at 2219.19, up 0.95% from the previous trading day. The index was able to rise to 2221.27, up 1.05% during the session, thanks to the strong performance of pharmaceutical, bio stocks, and untact-related stocks.

Among the top market capitalization stocks, large semiconductor stocks such as Samsung Electronics (1.29%) and SK Hynix (2.43%) rose, and bio sector stocks such as Samsung Biologics (1.35%) and Celltrion (2.01%) also showed strength. Untact stocks like NAVER and Kakao, which had undergone adjustments until the previous day, also rose by 2.66% and 3.23%, respectively, compared to the previous trading day.

However, Hyundai Motor and Hyundai Mobis, which had risen sharply recently, fell by 1.65% and 3.13%, respectively, compared to the previous trading day.

Pharmaceutical stocks surged on expectations for COVID-19 vaccine development research. Ilyang Pharmaceutical rose 24.85% compared to the previous trading day, while JW Pharmaceutical preferred shares (16.67%), Kwangdong Pharmaceutical (16.34%), Bukwang Pharmaceutical (16.88%), Kookje Pharmaceutical (15.35%), Daewon Pharmaceutical (9.73%), and Green Cross Holdings (10.13%) also rose sharply.

By investor type, individuals and institutions sold net 152.4 billion KRW and 32.3 billion KRW worth of stocks in the KOSPI market, respectively, while foreigners bought net 186 billion KRW worth.

As of 9:32 a.m. on the same day, the KOSDAQ index recorded 786.59, up 0.59% from the previous trading day.

Among the top market capitalization stocks, Celltrion Healthcare (0.96%), Seegene (1.96%), HL Biopharma (2.28%), and Celltrion Pharm (0.77%) rose.

5G-related stocks such as KMH (-0.84%), Oisolution (-1.71%), and RFHIC (-1.22%), which had shown recent upward trends, showed slight adjustments on the day.

In the KOSDAQ market, individuals sold net 14.6 billion KRW worth of stocks, while foreigners and institutions bought net 13.5 billion KRW and 5.4 billion KRW worth, respectively.

This content was produced with the assistance of AI translation services.